In vitro cytocidal effect of novel lytic peptides on Plasmodium falciparum and Trypanosoma cruzi
Document Type
Article
Publication Date
1-1-1988
Abstract
Plasmodium falciparum and Trypanosoma cruzi were killed by two novel lytic peptides (SB-37 and Shiva-1) in vitro. Human erythrocytes infected with P. falciparum, and Vero cells infected with T. cruzi, were exposed to these peptides. The result, in both cases, was a significant decrease in the level of parasite infection. Furthermore, the peptides had a marked cytocidal effect on trypomastigote stages of T. cruzi in media, whereas host eukaryotic cells were unaffected by the treatments. In view of the worldwide prevalence of these protozoan diseases and the lack of completely suitable treatments, lytic peptides may provide new and unique chemotherapeutic agents for the treatment of these infections.
Publication Source (Journal or Book title)
FASEB Journal
First Page
2878
Last Page
2883
Recommended Citation
Jaynes, J., Burton, C., Barr, S., Jeffers, G., Julian, G., White, K., Enright, F., Klei, T., & Laine, R. (1988). In vitro cytocidal effect of novel lytic peptides on Plasmodium falciparum and Trypanosoma cruzi. FASEB Journal, 2 (13), 2878-2883. https://doi.org/10.1096/fasebj.2.13.3049204